Mutations in LAMA2 cause severe congenital muscular dystrophy accompanied by nervous system defects [1]. Mice homozygous for the dy 2J allele of LAMA2 express a laminin α α2 subunit that has a deletion in the aminoterminal domain VI, providing an animal model for study of the molecular basis of congenital muscular dystrophy [2, 3] . Domain VI is predicted to be involved in laminin polymerization, along with amino-terminal domains from laminin β β and γ γ chains [4]. In a solutionpolymerization assay, we found that purified dy 2J laminin assembled poorly and formed little polymer, in contrast to wild-type muscle laminin. Furthermore, dissolution of the collagen IV network caused dy 2J laminin to be released into solution, indicating that laminin polymers within the skeletal muscle basement membrane were defective. In addition to loss of polymerization, dy 2J laminin had a reduced affinity for heparin. Finally, recombinant laminin engineered with the dy 2J deletion was more sensitive to proteolysis and was readily cleaved near the junction of domains V and VI. Thus, the dy 2J deletion selectively disrupts polymer formation, reduces affinity for heparin, and destabilizes domain VI. These are the first specific functional defects to be identified in a muscular dystrophy laminin, and it is likely that these defects contribute to the abnormalities seen in dy 2J /dy 2J muscle and nerve. 
Results and discussion
Mice homozygous for the dy 2J allele of LAMA2 express a laminin α2 subunit that has a 57 amino acid deletion and a Gln91Glu substitution within domain VI [2, 3] . The dy 2J laminin α2 subunit was reported to have an apparent molecular mass that, depending on the tissue, ranged from 10-55 kDa smaller than normal, which is seemingly at odds with a 57 amino acid deletion [2, 3] . To further investigate this discrepancy, we engineered a recombinant amino-terminal fragment of laminin α2 that had the same deletion as in the dy 2J allele, α2(VI-IVb)∆dy 2J . This was compared with dy 2J α2 from skeletal muscle and with a fragment without the deletion, α2(VI-IVb). Laminin-2/4, a mixture of laminin-2 (α2β1γ1) and laminin-4 (α2β2γ1), was extracted from wild-type and dy 2J /dy 2J skeletal muscle and analyzed by SDS-PAGE (Figure 1a ). The laminin α2 subunit had an apparent molecular weight of ~300 kDa, whereas the dy 2J α2 subunit was 25-30 kDa smaller. The engineered fragment α2(VI-IVb)∆dy 2J had an apparent molecular weight that was only 6 kDa smaller than that of α2(VI-IVb), however, a size difference more consistent with the removal of 57 amino acids ( Figure 1c , zero time points). We also noted a faster-migrating band (~100 kDa) in some of our preparations of α2(VI-IVb)∆dy 2J , which is likely to be a degradation product as it reacted with α2-specific antibodies (data not shown).
We compared the stability of α2(VI-IVb) and α2(VI-IVb)∆dy 2J using limited proteolysis and found that the mutant protein was cleaved by elastase at approximately 50 times the rate of wild-type protein (Figure 1c) . Furthermore, proteolysis resulted in a truncated protein with an apparent molecular weight of ~98 kDa. The truncated protein was sequenced from its amino terminus and found to have the sequence XVK(X/D)ISVGXM (in the single-letter amino acid code, where X is an unknown amino acid). This sequence corresponds to the last nine residues of domain VI, so the amino terminus of the truncated protein lies nine residues upstream from the predicted junction of domains VI and V [5] . These data suggest that the deletion destabilizes domain VI and exposes a proteolytically sensitive region just upstream of the junction of domains VI and V (Figure 1d ). We propose that the mutant domain VI is unstable and is easily truncated in vivo, accounting for the apparent difference from the wild-type molecular weight of 25-30 kDa that was consistent in all preparations of dy 2J /dy 2J skeletal muscle. Other tissues of dy 2J /dy 2J mice are reported to show distinct, yet consistent, changes in the molecular weight of laminin α2 [3] , so the degree of truncation that occurs in vivo may depend upon tissue-specific factors such as the local complement of proteases or posttranslational modifications.
Several lines of evidence suggest that expression of dy 2J laminin leads to muscle pathology through a misregulation of basement membrane architecture rather than through loss of binding sites for laminin receptors. First, dy 2J /dy 2J sarcolemmal basement membranes appear abnormal, but do not appear to have a large reduction in laminin α2. Immunofluorescence studies suggest that the amount of laminin α2 in dy 2J /dy 2J muscle is not significantly different than normal [2, 3] . Using the ratio of myosin mass to total mass as a corrective factor for fibrosis, we consistently observed levels of laminin α2 that were ~70% of those in normal mice (data not shown). Second, the principal receptors for α2 laminins in mature skeletal muscle are thought to be α7β1 integrin and dystroglycan, both of which bind exclusively to the carboxyterminal region of laminin-2/4 [6, 7] . Direct binding was not detected between α2(VI-IVb) and myotubes and addition of laminin carboxy-terminal fragments to myotubes completely prevented binding of laminin-2/4 [8] . Finally, laminins-2 and -4 are known to form a threedimensional, mesh-like polymer proposed to be mediated by interactions among the amino-terminal short arms of its α, β, and γ subunits [9, 10] . We observed differences in the solubility of laminin-2/4 isolated from the skeletal muscle of wild type and dy 2J /dy 2J mice. Collagenase was used to disrupt the type IV collagen network, which can link to the laminin network through interactions with entactin/nidogen [11] . Subsequent EDTA treatment was used to dissociate the calcium-dependent laminin polymer [12] and to disrupt laminin-receptor interactions. A large fraction (nearly 50%) of laminin-2/4 was released into solution from dy 2J /dy 2J skeletal muscle following collagenase treatment, whereas the majority of laminin-2/4 from wild-type skeletal muscle required additional treatment with EDTA to be solubilized (Figure 2a,b) . This difference in solubility indicated that dy 2J laminin was primarily associated with the basement membrane through surviving non-polymer bonds, such as linkage to the collagen IV network through entactin/nidogen. We next evaluated dy 2J laminin-2/4 purified from skeletal muscle in a copolymerization assay, which could detect the polymerization capacity of small quantities of protein [10] . Laminin-2/4 from wild-type skeletal muscle increasingly sedimented with the polymer fraction as total laminin concentration increased, whereas the majority of laminin-2/4 from dy 2J /dy 2J mice remained in the soluble pool (Figure 2c-e) . Thus, laminin-2/4 expressed by dy 2J /dy 2J mice is defective in its ability to form a laminin polymer.
Next, the ability of dy 2J laminin-2/4 to bind heparin was evaluated. Using high performance liquid chromatography (HPLC) heparin-affinity chromatography, we compared the elution positions of laminin-2/4 from normal and dy 2J /dy 2J mice (Figure 3 ). Although dy 2J laminin-2/4 bound heparin, it eluted at a lower salt concentration than normal laminin-2/4. Both proteins contain a heparinbinding region in the carboxy-terminal G domain that is known to mediate interactions with dystroglycan, a molecule that links the dystrophin-glycoprotein complex and the extracellular matrix [6, 7] . This site is unaffected in dy 2J /dy 2J mice, so the difference in relative heparin affinity must reflect changes in the second heparin-binding site, mapped to domain VI [13] . Basic amino acids arginine and lysine are thought to be essential for mediating electrostatic interactions with the negatively charged sulfate and carboxylic acid groups of heparin [14] . If a charge of +1 is assigned to arginine and lysine and -1 to aspartic acid and glutamic acid, wild-type domain VI has a net positive charge of +2 and dy 2J domain VI has a net loss of basic residues that reduces the net charge to zero. Furthermore, two N-glycosylation consensus sites are deleted in dy 2J α2, which may contribute to changes in heparin binding as well as to decreased stability. It is possible that the loss of these positively charged residues disrupts a crucial interaction with molecules containing negatively charged groups such as heparan sulfate or polysialic acid, but an in vivo role for the heparin binding site in domain VI has yet to be established. Limited proteolysis of wild-type and dystrophic α2(VI-IVb) shows that the dy 2J domain VI is more sensitive to proteolysis and is truncated. (a) SDS-PAGE under reducing conditions of laminin-2/4 extracted from wild-type (+/+) and dy 2J /dy 2J mice. Laminins were isolated using collagenase, EDTA, and heparin-affinity chromatography. The laminin α2 chain migrates faster; its apparent molecular mass is ~25 kDa less than that of wild-type α2 (300 vs 275 kDa). (b) Schematic representation of the α2(VI-IVb)∆dy 2J engineered laminin fragment. The amino-terminal region of the laminin α2 chain has a 57 amino acid deletion and Gln91Glu substitution (arrow) within domain VI. (c) Fragments α2(VI-IVb) and α2(VI-IVb)∆dy 2J were found to migrate with relative molecular masses of 122 kDa and 116 kDa, respectively, a difference of ~6 kDa (see zero time points). Protein fragments were digested with elastase for the indicated times at 25°C (enzyme:substrate ratio 1:50) and evaluated under reducing conditions. The α2(VI-IVb) fragment was fairly resistant to elastase over time, whereas α2(VI-IVb)∆dy 2J was readily degraded to a smaller apparent molecular mass of 98 kDa (~24 kDa smaller than α2(VI-IVb)). Aminoterminal sequencing of the 98 kDa fragment (data not shown) indicated that domain VI was completely removed, with the exception of nine amino acids. (d) Model of the probable reason for the much smaller molecular weight of dy 2J /dy 2J laminin than predicted from its structure. Deletion of 57 amino acids in domain VI exposes a proteolytically sensitive region just upstream of the junction with domain V. Proteolysis therefore leads to degradation of nearly all of domain VI. Laminin polymerization may be important for maintaining the structural integrity of the basement membrane, given the alterations seen in dy 2J /dy 2J mice. Several factors suggest this may not be the only role for laminin polymerization, however. For instance, the collagen IV network assembles through interactions of considerably higher affinity than laminin self-assembly interactions. Although the collagen IV network is present in the basement membranes of dy 2J /dy 2J mice, it clearly does not compensate for the functional deficits in laminin. Furthermore, one might expect a defect caused by structural weakness to be much more pronounced at points of attachment like the muscle-tendon junction, but there is no evidence for such a defect.
An additional role for laminin polymerization was described recently, in which polymerization was found to induce changes in the organization of muscle receptors and of components of the cortical cytoskeleton such as dystrophin and vinculin [8] . In agreement with this hypothesis, the sarcolemmal cortex of dy 2J /dy 2J skeletal muscle has a grossly irregular appearance in transmission electron micrographs (H.C. and P.D.Y., unpublished observations). Based on the data presented here, an emerging hypothesis is that laminin polymerization may be required for the development or maintenance of proper cortical architecture in the muscle sarcolemma ( Figure 4 ). It is also realistic to assume that architectural changes propagated from basement membrane to cytoskeleton may have profound signaling consequences, as has been found for fibronectin fibrillogenesis [15] [16] [17] [18] . The differential ability of various laminins to polymerize may represent a normal regulatory mechanism by which different laminins transmit different signals using common receptors.
As well as the muscle defect, dy 2J /dy 2J mice have poorly myelinated axons. Evaluation of this defect may prove to be more complex. In contrast to skeletal muscle, evidence suggests that Schwann cell receptors interact with domain VI of laminin α2. Schwann cells express high levels of the Brief Communication 1329 Laminin polymer formation was evaluated in a sedimentation assay in which the degree of polymer formation has been found to be independent of the concentration of test laminin [10] . Briefly, fixed amounts of laminin-2/4 extracted from skeletal muscle (test laminin) were added to aliquots containing various concentrations of laminin-1 (Lm-1) and incubated at 37°C for 3 h. Differential centrifugation was used to pellet the laminin polymer, and unpolymerized laminin remained in solution. Immunoblots of supernatant (S) and polymer (P) fractions were probed with an antibody that recognizes the laminin α2 subunit. Bands were visualized using a DuraSuperSignal chemiluminescence detection kit (Pierce) and quantitated by PhosphoAnalysis (BioRad). Wild-type laminin-2/4 copolymerized with laminin-1 and at higher laminin-1 concentrations was increasingly found in the polymer fraction, whereas dy 2J /dy 2J laminin-2/4 remained largely in the supernatant fraction. (e) Graph of the fraction of laminin α2 subunit that appeared as polymer versus total laminin concentration. α1β1 integrin [19] , an integrin that interacts with domain VI of the laminin α2 chain [13] . Preliminary data suggest that interactions between primary Schwann cells and the amino-terminal region of laminin α2 may in part be mediated by additional receptor(s) (H.C. and P.D.Y., unpublished observations). Because of its heparin-binding characteristics, domain VI is also a good candidate to interact with negatively charged groups like sulfated glycosaminoglycan chains or polysialic acid. As sulfated proteoglycans and polysialic acid epitopes are highly expressed in the central nervous system, the brain abnormalities seen in many LAMA2 congenital muscular dystrophies may involve loss of such interactions. 
